The Global Health Impact
Patent Holder Index.
Evaluating how pharmaceutical companies’ drugs impact the health of populations devastated by disease. It is usually the case that those who are burdened most by these diseases live on less a dollar a day.
Company scores are the combined total of the impact of their drugs on death and disability around the world. Three aspects are taken into consideration when determining country scores: The need for several important drugs in each country, the drugs’ effectiveness, and the number of people that can access them.
Proportion of Global Disease Burden Alleviated by Originator Company’s Drugs — Whipworm
Comparative Global Health Impact of Originator Companies
Limitations
The rankings on this website are meant to provide a metric of the impacts of pharmaceutical companies’ drugs on a few important global diseases. This index is not meant to measure how “good” a pharmaceutical company is in relation to its peers, or how effective it has been at ensuring access to its drugs. The impacts of the ranked companies’ drugs is only one of many measures of a company’s overall fulfillment of its social responsibilities.
For instance, companies with high scores on this index may have poor access policies and those with lower scores better access policies.
“For a more comprehensive view that takes into account the vital role of generics companies in ensuring access to essential medicines, see the manufacturers’ tab.”